Guangzhou Wondfo Biotech Co.,Ltd (SHE:300482)
China flag China · Delayed Price · Currency is CNY
18.68
+0.23 (1.25%)
Apr 24, 2026, 3:04 PM CST

SHE:300482 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
371.23462.53828.69840.31,163996.15
Short-Term Investments
--62.86623.04200.26-
Trading Asset Securities
1,6001,2641,306722.45938.07572.73
Cash & Short-Term Investments
1,9711,7272,1982,1862,3011,569
Cash Growth
1.89%-21.42%0.55%-5.00%46.66%3.84%
Accounts Receivable
779.28791.881,130599.87540.97501.78
Other Receivables
47.8244.1344.2551.7266.664.7
Receivables
827.1836.011,174651.59607.57566.48
Inventory
274.03280.58359.56351.4399.97386.24
Other Current Assets
384.67457.754.1744.574263.9
Total Current Assets
3,4573,3013,7863,2333,3502,586
Property, Plant & Equipment
1,4191,4541,4841,3531,189906.09
Long-Term Investments
1,3491,3161,391709.481,284971.42
Goodwill
108.97108.97111.42111.42115.3742.51
Other Intangible Assets
243.19245.69205.51194.52203.71208.11
Long-Term Deferred Tax Assets
97.59112.6976.1857.4753.8642.77
Long-Term Deferred Charges
37.4841.0256.4680.0365.0469.76
Other Long-Term Assets
22.0722.3444.5932.8339.4129.66
Total Assets
6,7346,6027,1555,7726,3014,856
Accounts Payable
258.79210.81288.37130.46320.08399.99
Accrued Expenses
61.0674.09201.41193.5229.74184.01
Short-Term Debt
-0.0114.854.26208.4219.14
Current Portion of Long-Term Debt
599.28592.38---12.53
Current Portion of Leases
--5.4119.0116.8628.24
Current Income Taxes Payable
19.037.6442.621.8458.734.69
Current Unearned Revenue
65.3175.6677.172.88236.3180.55
Other Current Liabilities
69.2178.29191.7342.2970.9162.4
Total Current Liabilities
1,0731,039821.46484.231,141791.54
Long-Term Debt
--570.97552.84532.49510.69
Long-Term Leases
8.219.2614.3327.6911.1910.42
Long-Term Unearned Revenue
43.6444.5447.9437.2123.19.4
Long-Term Deferred Tax Liabilities
31.8235.4449.6655.1255.7529.7
Total Liabilities
1,1561,1281,5041,1571,7641,352
Common Stock
468.09468.08481.42444.52444.51444.95
Additional Paid-In Capital
1,3991,3991,458765.52775.53787.01
Retained Earnings
3,6413,5573,8073,4333,1662,101
Treasury Stock
-30.09-30.09-171.02-132.46-157.3-139.25
Comprehensive Income & Other
39.3221.2-21.295.9115.39159.18
Total Common Equity
5,5175,4155,5544,5164,3443,353
Minority Interest
60.6658.9395.998.66193.8150.97
Shareholders' Equity
5,5785,4745,6504,6154,5383,504
Total Liabilities & Equity
6,7346,6027,1555,7726,3014,856
Total Debt
607.48601.65605.57603.8768.96581.01
Net Cash (Debt)
1,3641,1251,5921,5821,532987.87
Net Cash Growth
1.89%-29.32%0.65%3.27%55.07%9.88%
Net Cash Per Share
2.842.323.433.573.472.23
Filing Date Shares Outstanding
468.89506.3477.87440.96441.26444.95
Total Common Shares Outstanding
468.89506.3477.87440.96441.26444.95
Working Capital
2,3842,2622,9642,7492,2091,794
Book Value Per Share
11.7710.6911.6210.249.847.54
Tangible Book Value
5,1655,0605,2374,2104,0253,102
Tangible Book Value Per Share
11.029.9910.969.559.126.97
Buildings
--1,007530.37447.3436.03
Machinery
--1,0711,021940.43741.37
Construction In Progress
--5.12290.84199.1416.38
Source: S&P Global Market Intelligence. Standard template. Financial Sources.